Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

63.47
+3.565.94%
Post-market: 63.940.4700+0.74%19:44 EDT
Volume:640.79K
Turnover:40.08M
Market Cap:1.81B
PE:162.74
High:64.00
Open:59.76
Low:59.76
Close:59.91
52wk High:64.00
52wk Low:14.27
Shares:28.58M
Float Shares:26.68M
Volume Ratio:0.56
T/O Rate:2.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:38.94
PE(LYR):-371.19

Loading ...

GUIDANCE: (ETON) Eton Pharmaceuticals Expects 2026 Revenue to Exceed $120M, vs. FactSet Est of $108.4M

MT Newswires Live
·
May 15

Eton Pharmaceuticals Q1 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $24.266M Beat $22.312M Estimate

Benzinga Earnings
·
May 15

BRIEF-Eton Pharmaceuticals Q1 Net Income USD 1.554 Million

Reuters
·
May 15

Eton Pharmaceuticals Q1 EPS USD 0.05

THOMSON REUTERS
·
May 15

Eton Pharmaceuticals Q1 Revenue USD 24.3 Million

THOMSON REUTERS
·
May 15

Eton Pharmaceuticals: Expects to Report at Least 30% Adj Ebitda Margin for FY 2026

THOMSON REUTERS
·
May 15

Eton Pharmaceuticals Outlook FY Revenues to Exceed $120 Million

THOMSON REUTERS
·
May 15

U.S. Earnings Preview: After Market Close May 14

Dow Jones
·
May 15

Eton Pharmaceuticals Inc expected to post earnings of 9 cents a share - Earnings Preview

Reuters
·
May 13

Eton Pharma management attends Jefferies Global Healthcare Conference webcast

Reuters
·
May 13

Eton Pharmaceuticals to report Q1 2026 results, host conference call

Reuters
·
May 05

Eton Pharmaceuticals Touches New High Amid Relaunch of Hemangeol

Dow Jones
·
May 02

Eton Pharmaceuticals Relaunches Hemangeol® (Propranolol) Oral Solution With Eton Cares and Exclusive Specialty Pharmacy Distribution

THOMSON REUTERS
·
May 01

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Eton Pharmaceuticals (ETON) and Ligand Pharma (LGND)

TIPRANKS
·
Apr 27

Eton Pharmaceuticals says first patient dosed in study of ET-700

TIPRANKS
·
Apr 27

Eton Pharmaceuticals doses first patient in ET-700 Wilson disease pilot trial

Reuters
·
Apr 27

Eton Pharmaceuticals Inc - Topline Results From Et-700 Pilot Study Expected in Second Half of 2026

THOMSON REUTERS
·
Apr 27

Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate Et-700

THOMSON REUTERS
·
Apr 27

Eton Pharmaceuticals announces annual shareholder meeting notice

Reuters
·
Apr 25

Eton Pharmaceuticals Names Judith Matthews CFO

MT Newswires Live
·
Apr 16